Volume 2, Issue 2
Editorialp. 121–124
Statistical issues in trial design and personalized medicine
Author(s): Feifang Hu
Opinion Articlep. 125-127
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Author(s): Paul Wicks
Research Updatep. 133-138
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Author(s): Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Clinical Trail Perspectivep. 139-146
Research involving pregnant women: trials and tribulations
Author(s): Francoise Baylis, Scott A. Halperin
Clinical Trail Methodologyp. 147-152
Trial discontinuation: lessons for future trial design?
Author(s): Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodologyp. 153-162
New considerations in the design of clinical trials for traumatic brain injury
Author(s): Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
Clinical Trail Methodologyp. 163-175
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Author(s): Donald R VanDevanter,Michael W Konstan
Therapeutic Perspectivep. 177-188
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Author(s): Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Review: Clinical Trail Outcomesp. 189-198
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Author(s): Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomesp. 199-206
Clinical evidence of the role of edoxaban in anticoagulation
Author(s): Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomesp. 207-213
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Author(s): Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Special Reportp. 215-223
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Author(s): Lucy Lee
